front and rear parking sensors, rear parking camera, smart 17-inch alloy wheels and a host of safety systems to give peace of mind. The EV3 is efficient, too – we've seen nearly 5.0m/kWh in ...

Among the most compelling is the Cupra Born, which takes up similar space on the road to a Volkswagen Golf, and has a maximum range that’s just three miles short of the EV3’s. We find out ...

This proactive tool monitors electrical flow to help protect your home from hidden fire hazards, and might be available for free from your home insurance company Senior editor, Buy Side from WSJ ...

When Is The 2026 Kia EV3 Coming Out? There is no firm release date for the 2026 Kia EV3, with some sources expecting the car to debut as a 2025 model, but the most reliable information suggests ...

Sensify is a new technology that can turn Zigbee switches, bulbs, and plugs into sensors with a firmware update. This could be how Philips Hue will bring ambient sensing to its smart lights.

Even the new Kia EV3 Air has a good level of standard equipment, including 17-inch alloys, front and rear parking sensors, heated front seats and steering wheel, front and rear parking cameras and ...

The F-22 will receive an embedded set of TacIRST sensors as part of the Infrared Defensive System to enhance aircraft survivability and lethality. Lockheed Martin announced on Jan. 22, 2025 ...

Still, it’s no worse than in a Kona Electric or #3, and every EV3 comes with front and rear parking sensors and a rear-view camera as standard. Range-topping GT-Line S trim adds a 360-degree ...

What awards has Edward Gero won? Edward Gero has received several awards, including: - Outstanding Lead Actor, Resident Play (Helen Hayes Awards) for Skylight - Outstanding Supporting Actor ...

Just a few weeks France's Sanofi made a $40 million investment in Gyroscope for first refusal rights on the gene therapy – called GT005 – but it is Novartis that has swooped on the company and ...

French drugmaker Sanofi has made a $40 million investment in Gyroscope Therapeutics, with another $20 million potentially on offer as the UK biotech advances its clinical-stage gene therapies for ...